FULC
NASDAQ · Pharmaceuticals
Fulcrum Therapeutics Inc
$6.77
-0.27 (-3.84%)
Open$7.04
Previous Close$7.04
Day High$7.15
Day Low$6.72
52W High$15.74
52W Low$2.32
Volume—
Avg Volume606.1K
Market Cap773.83M
P/E Ratio—
EPS$-0.86
SectorPharmaceuticals
Analyst Ratings
Strong Buy
16 analysts
Price Target
+741.7% upside
Current
$6.77
$6.77
Target
$56.98
$56.98
$37.54
$56.98 avg
$60.88
Key Financials
| FY 2026 | FY 2025 | FY 2024 | |
|---|---|---|---|
| Revenue | 88.39M | 54.89M | 366.88M |
| Net Income | -10,744,616 | -6,005,188 | 47.13M |
| Profit Margin | -12.2% | -11.6% | 12.9% |
| EBITDA | -8,984,663 | -5,300,521 | 69.95M |
| Free Cash Flow | — | — | 54.75M |
| Rev Growth | +61.0% | +61.0% | +22.0% |
| Debt/Equity | — | — | 0.65 |
Pharmaceuticals Peers
| Symbol | Name | Price | Change | P/E | Mkt Cap |
|---|---|---|---|---|---|
| LLY | Eli Lilly and Co. | $916.31 | +1.47% | 46.4 | 957.52B |
| JNJ | Johnson & Johnson | $239.93 | +1.98% | 22.2 | 594.00B |
| MRK | Merck & Co. Inc. | $119.37 | +2.58% | 16.5 | 301.17B |
| PFE | Pfizer Inc. | $27.28 | +1.19% | 19.7 | 153.36B |
| BMY | Bristol-Myers Squibb Co | $58.94 | +2.70% | 16.5 | 116.58B |
| ZTS | Zoetis Inc | $116.71 | +0.67% | 21.5 | 57.37B |